Nirmatrelvir/Ritonavir Versus Remdesivir Therapy for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Kidney Transplant Recipients: A Retrospective Study

Background

The prognosis of coronavirus disease-2019 (COVID-19) in solid organ transplant recipients is extremely poor. The efficacy and safety of various treatments used in COVID-19 have not been fully explored in kidney transplant recipients (KTRs). This study aims to investigate the safety and efficacy of nirmatrelvir/ritonavir versus remdesivir in adult KTRs infected with COVID-19.